Held September 8-9 in Washington, DC, World Anti-Microbial Resistance Congress USA will bring together pharma, biotech, hospitals, government and their partners to discuss the world’s most important health issue.
Since their first use, antibiotics have been viewed as a sort of superdrug, able to take on even the most determined infectious diseases. In recent years, however, growing dependence upon and now resistance to these antibiotics has brought on the strengthening of superbugs and other infectious diseases, making diagnosis and treatment more and more difficult. What’s more, the antibiotic pipeline has been at a near standstill, as the pharma industry has become skeptical of the return on investments in antibiotic R&D.
The World Anti-Microbial Resistance Congress USA brings together leaders in the industries of pharma, biotech, hospitals, government and their partners, providing a platform for discussion and development of solutions to this growing issue.
Are there other innovative and alternative ways to public-private partnerships? How can developing new antibiotics make more business sense? How can the GAIN act be improved? Have other measures of infection prevention such as new vaccines been considered? The World Anti-Microbial Resistance Congress will discuss the answers to these questions and more.
This 2-day conference presents solutions through key notes, case study presentations, expert opinion, and roundtable discussions, and invites key influencers such as BARDA, NIH, FDA, grant agencies, pharma, hospitals, and academia into the AMR discussion.
Register here: http://goo.gl/4o1pGJ
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 547
- Comments 0